[Treatment of hyperlipidemia in the prevention of ischemic heart disease. A proposal for the unification of medical management. I and II].
Adamska-Dyniewska
H
H
Chojnowska-Jezierska
J
J
Cybulska
B
B
Dzieniszewski
J
J
Hryniewiecki
L
L
Idzior-Waluś
B
B
Jabłońska-Kaszewska
I
I
Jaszcz-Kanecka
A
A
Kłosiewicz-Latoszek
L
L
Kokot
F
F
D003131:Combined Modality Therapy / Q000592:standards; D003327:Coronary Disease / Q000209:etiology / Q000517:prevention & control*; D004041:Dietary Fats / Q000008:administration & dosage* / Q000592:standards; D005060:Europe; D006801:Humans; D006937:Hypercholesterolemia / Q000150:complications / Q000628:therapy; D006949:Hyperlipidemias / Q000150:complications / Q000628:therapy*; D006954:Hyperlipoproteinemia Type V / Q000150:complications / Q000628:therapy; D015228:Hypertriglyceridemia / Q000150:complications / Q000628:therapy; D000960:Hypolipidemic Agents / Q000008:administration & dosage* / Q000592:standards; D007391:International Cooperation; D009316:National Institutes of Health (U.S.); D011044:Poland; D012307:Risk Factors; D014481:United States
D004041:Dietary Fats; D000960:Hypolipidemic Agents
Leczenie hiperlipidemii w profilaktyce niedokrwiennej choroby serca. Propozycja unifikacji postepowania lekarskiego. (Cześć I).